July 31 (Reuters) – Canada’s Valeant Pharmaceuticals International Inc, embroiled in a bitter battle to take over Botox-maker Allergan Inc, cut its full-year profit and revenue forecasts to reflect…

from Reuters: Mergers News http://ift.tt/1m0IJPR
via IFTTT

Publicités